These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38671927)

  • 1. Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Argelich E; Casares M; Ugarriza L; Llompart I; Tur JA; Sureda A
    Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Adherence to the Mediterranean Diet after Lifestyle Intervention Improves Oxidative and Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 35892642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Mascaró CM; Ugarriza L; Casares M; Llompart I; Abete I; Zulet MÁ; Martínez JA; Tur JA; Bouzas C
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés M; Bouzas C; Montemayor S; Mascaró CM; Casares M; Llompart I; Gámez JM; Tejada S; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease.
    Monserrat-Mesquida M; Quetglas-Llabrés MM; Bouzas C; Pastor O; Ugarriza L; Llompart I; Cevallos-Ibarra K; Sureda A; Tur JA
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediterranean Diet Improves Plasma Biomarkers Related to Oxidative Stress and Inflammatory Process in Patients with Non-Alcoholic Fatty Liver Disease.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; Llompart I; Mateos D; Casares M; Ugarriza L; Martínez JA; Tur JA; Sureda A
    Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study.
    Montemayor S; Bouzas C; Mascaró CM; Casares M; Llompart I; Abete I; Angullo-Martinez E; Zulet MÁ; Martínez JA; Tur JA
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
    Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
    Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the Mediterranean diet and risk of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A cross-sectional analysis of the RaNCD cohort.
    Miryan M; Darbandi M; Moradi M; Najafi F; Soleimani D; Pasdar Y
    Front Nutr; 2023; 10():1062008. PubMed ID: 36908910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial.
    Candás-Estébanez B; Fernández-Cidón B; Corbella E; Tebé C; Fanlo-Maresma M; Esteve-Luque V; Salas-Salvadó J; Fitó M; Riera-Mestre A; Ros E; Pintó X
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial.
    George ES; Reddy A; Nicoll AJ; Ryan MC; Itsiopoulos C; Abbott G; Johnson NA; Sood S; Roberts SK; Tierney AC
    Liver Int; 2022 Jun; 42(6):1308-1322. PubMed ID: 35357066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients.
    Świderska M; Maciejczyk M; Zalewska A; Pogorzelska J; Flisiak R; Chabowski A
    Free Radic Res; 2019 Aug; 53(8):841-850. PubMed ID: 31234658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial.
    Quetglas-Llabrés MM; Monserrat-Mesquida M; Bouzas C; García S; Mateos D; Casares M; Gómez C; Ugarriza L; Tur JA; Sureda A
    Antioxidants (Basel); 2024 Jun; 13(7):. PubMed ID: 39061823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorating effect of probiotic on nonalcoholic fatty liver disease and lipolytic gene expression in rabbits.
    Aziz M; Hemeda SA; Albadrani GM; Fadl SE; Elgendey F
    Sci Rep; 2023 Apr; 13(1):6312. PubMed ID: 37072469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
    Jiang W; Guo MH; Hai X
    World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ad libitum Mediterranean diet reduces subcutaneous but not visceral fat in patients with coronary heart disease: A randomised controlled pilot study.
    Mayr HL; Itsiopoulos C; Tierney AC; Kucianski T; Radcliffe J; Garg M; Willcox J; Thomas CJ
    Clin Nutr ESPEN; 2019 Aug; 32():61-69. PubMed ID: 31221292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of apple consumption on plasma and erythrocyte antioxidant parameters in elderly subjects.
    Avci A; Atli T; Ergüder IB; Varli M; Devrim E; Turgay SA; Durak I
    Exp Aging Res; 2007; 33(4):429-37. PubMed ID: 17886017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: The MEDINA randomized controlled trial.
    Reddy A; Gatta PD; Mason S; Nicoll AJ; Ryan M; Itsiopoulos C; Abbott G; Johnson NA; Sood S; Roberts SK; George ES; Tierney AC
    Nutr Res; 2023 Nov; 119():98-108. PubMed ID: 37801761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective effects of Shilajit on high fat-diet induced non-alcoholic fatty liver disease (NAFLD) in rats.
    Ghezelbash B; Shahrokhi N; Khaksari M; Ghaderi-Pakdel F; Asadikaram G
    Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32083445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.